Inventor · disambiguated record
Ting Li
Also filed as: LI TING · LI TING LM
13 granted patents·5 pending applications·3 citations·filing 2011–2022
84Inventor score
Files withTASLY PHARMACEUTICAL GROUP CO7UNIV MACAU SCI & TECH4LIU LIANG2HENAN TAIFENG BIOLOGICAL TECH CO LTD1IBM1
Top patents by PatentIndex Score
18 records- 0179US12090138B2Pharmaceutical composition containing silybin and VETASLY PHARMACEUTICAL GROUP CO·Filed 2022·Granted Sep 17, 2024·0 cites·8 claims
- 0276US9688997B2Genetically modified plants with resistance to Xanthomonas and other bacterial plant pathogensUNIV IOWA STATE RES FOUND INC·Filed 2012·Granted Jun 27, 2017·2 cites·27 claims
- 0374US9901566B1Limonoids for treating autoimmune diseasesUNIV MACAU SCI & TECH·Filed 2017·Granted Feb 27, 2018·1 cites·19 claims
- 0465US10307395B2Pharmaceutical composition containing silybin and L-carnitineTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Jun 4, 2019·0 cites·20 claims
- 0565US10307396B2Pharmaceutical composition containing silybin, VE and L-carnitineTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Jun 4, 2019·0 cites·20 claims
- 0661US10507197B2Pharmaceutical composition containing silibininTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Dec 17, 2019·0 cites·20 claims
- 0760US11318112B2Pharmaceutical composition containing silybin and veTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted May 3, 2022·0 cites·18 claims
- 0860US10376491B2Pharmaceutical composition containing silibinin and pueraria root extractTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Aug 13, 2019·0 cites·20 claims
- 0958US9018196B2Development of a new formulation overcoming thymus atrophy with concomitantly enhancement of anti-inflammatory effect of dexamethasoneUNIV MACAU SCI & TECH·Filed 2014·Granted Apr 28, 2015·0 cites·11 claims
- 1055US12104189B2Mutant of nitrile hydratase derived from Caldalkalibacillus thermarumUNIV JIANGNAN·Filed 2021·Granted Oct 1, 2024·0 cites·10 claims
- 1152US2015031050A1Method of Screening Therapeutic Agent for Treating Inflammatory DiseasesUNIV MACAU SCI & TECH·Filed 2014·Application pending·0 cites
- 1251US9955676B2Transgenic model for delay-type hypersensitivity (DTH) and use thereofUNIV MACAU SCI & TECH·Filed 2015·Granted May 1, 2018·0 cites·10 claims
- 1349US2023065462A1Pharmaceutical composition and use thereofHENAN TAIFENG BIOLOGICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 1447US2013210875A1Novel binding site of IKK-betaLIU LIANG·Filed 2012·Application pending·0 cites
- 1545US2023103033A1Two-phased medical diagnosisIBM·Filed 2021·Application pending·0 cites
- 1638US2012053235A1Dihydromyricetin as an IKK-beta inhibitor used for treatment of arthritis, cancer and autoimmune conditions, and other diseases or disordersLIU LIANG·Filed 2011·Application pending·0 cites
- 1737US10376490B2Pharmaceutical composition containing silybinTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Aug 13, 2019·0 cites·17 claims
- 1835US11322701B2High dielectric constant composite material and application thereofUNIV PEKING SHENZHEN GRADUATE SCHOOL·Filed 2017·Granted May 3, 2022·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Ting Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →